You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Osmotic demyelination syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyponatremia, Osmotic Demyelination Syndrome Trial in Bangkok (3%NaCl)

Unknown status
  • Hyponatremia
  • Osmotic Demyelination Syndrome
  • 3%NaCl
  • Bangkok, Thailand
    Rajavithi Hospital
Feb 24, 2021

Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination Trial (Tysabri Injectable Product, Placebo)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome of Demyelination
  • Tysabri Injectable Product
  • Placebo
  • London, United Kingdom
    Royal London Hospital
Jan 25, 2023

Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine

Not yet recruiting
  • Demyelinating Diseases
  • +4 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023

Microbiota Trial in Graz (Macrogol)

Completed
  • Microbiota
  • Graz, Styria, Austria
    Universitätsklinikum Graz
Aug 10, 2020

Osmotic Therapy for Patients With Severe Subarachnoid Hemorrhage

Not yet recruiting
  • Subarachnoid Hemorrhage, Traumatic
    • Beijing, Beijing, China
      Xuanwu Hospital
    May 12, 2023

    Back Pain Trial (Pilates Exercise, Mckenzie Exercise)

    Not yet recruiting
    • Back Pain
    • Pilates Exercise
    • Mckenzie Exercise
    • (no location specified)
    Jun 1, 2023

    Liver Transplantation Trial in Antalya (S100ß and Neuron specific enolase (NSE))

    Completed
    • Liver Transplantation
    • S100β and Neuron specific enolase (NSE)
    • Antalya, Turkey
      Akdeniz University Medical Faculty Department of Anesthesiology
    Jul 27, 2021

    Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric

    Not yet recruiting
    • Stroke
    • Osmotic drugs
    • Fuzhou, Fujian, China
    • +18 more
    Jun 20, 2023

    CNS Inflammatory Demyelinating Diseases

    Not yet recruiting
    • Multiple Sclerosis
    • +4 more
    • Intravenous steroid
    • (no location specified)
    Nov 29, 2021

    Carpal Tunnel Syndrome Trial in Scottsdale, Rochester (FDA approved ultrasound system with shear wave elastography capability)

    Enrolling by invitation
    • Carpal Tunnel Syndrome
    • FDA approved ultrasound system with shear wave elastography capability
    • Scottsdale, Arizona
    • +1 more
    Jan 10, 2023

    Irritable Bowel Syndrome Trial in Gothenburg (Traditional dietary advice and low FODMAP content, Low carbohydrate diet,

    Completed
    • Irritable Bowel Syndrome
    • Traditional dietary advice and low FODMAP content
    • +2 more
    • Gothenburg, Non-US/Non-Canadian, Sweden
      Magnus Simren
    Oct 24, 2022

    Longitudinal Cortical Demyelination in Multiple Sclerosis and

    Recruiting
    • Multiple Sclerosis
    • +2 more
      • New York, New York
        Mount Sinai Hospital
      Aug 8, 2023

      HIV-1 Trial (Doravirine, Darunavir, Ritonavir)

      Active, not recruiting
      Has Results
      • HIV-1
      • (no location specified)
      Aug 19, 2022

      Pain Alleviation, Dilatation and Evacuation, Laminaria Placement Trial in Ramat Gan (Nitrous oxide (N2O/O2), Oxygen (O2))

      Not yet recruiting
      • Pain Alleviation
      • +3 more
      • Nitrous oxide (N2O/O2)
      • Oxygen (O2)
      • Ramat Gan, Israel
        Sheba Medical Center
      Oct 11, 2022

      Radiologically Isolated Syndrome, Multiple Sclerosis Trial in United States (Ocrelizumab, Placebo)

      Recruiting
      • Radiologically Isolated Syndrome
      • Multiple Sclerosis
      • Los Angeles, California
      • +15 more
      Jan 30, 2023

      Study of Smith-Lemli-Opitz Syndrome

      Completed
      • Smith-Lemli-Opitz Syndrome
      • Cholesterol Suspension
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Central and Peripheral Nervous System Changes as Markers of

      Completed
      • Multiple Sclerosis
      • +7 more
        • Sønderborg, Jylland, Denmark
          Department of Neurology (Skleroseklinikken), Sygehus Sønderjylla
        Oct 13, 2021

        Hyponatremia Trial (DDAVP, Standard hyponatremia treatment)

        Not yet recruiting
        • Hyponatremia
        • DDAVP
        • Standard hyponatremia treatment
        • (no location specified)
        Aug 28, 2023

        Multiple Sclerosis Trial in Ladera Ranch (Entire-body PET-CT scans, Amyvid radiopharmaceutical)

        Recruiting
        • Multiple Sclerosis
        • Entire-body PET-CT scans
        • Amyvid radiopharmaceutical
        • Ladera Ranch, California
          Brain Health Alliance
        Mar 31, 2022

        Osmotic Fragility in Red Blood Cells of Pediatric Cholestatic

        Active, not recruiting
        • Cholestasis
        • Red Cell Membrane and Enzyme Abnormalities
        • ektacytometry of red blood cells
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Oct 12, 2022

        Acute Kidney Injury in Diabetic Ketoacidosis at Sohag University

        Not yet recruiting
        • Diabetic Ketoacidosis
        • Acute Kidney Injury
          • (no location specified)
          May 18, 2023

          Prognostic Factors of Gullian Barrie Syndrome Outcome

          Completed
          • Guillain-Barre Syndrome
          • plasmapheresis
          • Assuit, Assiut, Egypt
            Assiut university
          Dec 7, 2022

          Kidney Stone Trial in Montréal (Ure-Na)

          Withdrawn
          • Kidney Stone
          • Montréal, Quebec, Canada
            Centre Hospitalier de l'Université de Montréal (CHUM)
          Nov 22, 2022

          Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP

          Not yet recruiting
          • CIDP
          • IVIg
          • Nashville, Tennessee
            Vanderbilt University
          Nov 4, 2022

          Radiation Necrosis Trial in Lexington, Louisville (25% Mannitol, Low-dose Intra-arterial Bevacizumab)

          Completed
          Has Results
          • Radiation Necrosis
          • 25% Mannitol
          • Low-dose Intra-arterial Bevacizumab
          • Lexington, Kentucky
          • +1 more
          May 2, 2022